Johnny Andrew’s Post

𝑬𝒙𝒄𝒊𝒕𝒊𝒏𝒈 𝑼𝒑𝒅𝒂𝒕𝒆𝒔 𝒊𝒏 𝒕𝒉𝒆 𝑫𝒊𝒂𝒍𝒚𝒔𝒊𝒔 𝑴𝒂𝒓𝒌𝒆𝒕! 𝑹𝒆𝒒𝒖𝒆𝒔𝒕 𝒇𝒐𝒓 𝒂 𝑭𝑹𝑬𝑬 𝑺𝒂𝒎𝒑𝒍𝒆: https://lnkd.in/gyT8wF4A As the healthcare industry continues to innovate and evolve, I'm thrilled to share some key insights into the dialysis market! Here's a glimpse into the latest developments: 𝑴𝒂𝒓𝒌𝒆𝒕 𝑮𝒓𝒐𝒘𝒕𝒉: The dialysis market has been experiencing steady growth, driven by factors such as increasing prevalence of kidney diseases, technological advancements, and growing awareness about renal health. 𝑻𝒆𝒄𝒉𝒏𝒐𝒍𝒐𝒈𝒊𝒄𝒂𝒍 𝑨𝒅𝒗𝒂𝒏𝒄𝒆𝒎𝒆𝒏𝒕𝒔: Innovations in dialysis technology have been remarkable, with the introduction of wearable and portable dialysis devices, enhanced filtration techniques, and improved biocompatible materials, offering greater convenience and efficiency for patients. 𝑮𝒍𝒐𝒃𝒂𝒍 𝑹𝒆𝒂𝒄𝒉: The demand for dialysis services is not limited to any particular region, with significant growth observed worldwide. Emerging economies are witnessing a surge in demand for dialysis treatments due to changing lifestyles and rising incidences of chronic diseases. 𝑷𝒂𝒕𝒊𝒆𝒏𝒕-𝑪𝒆𝒏𝒕𝒆𝒓𝒆𝒅 𝑪𝒂𝒓𝒆: Healthcare providers are increasingly focusing on delivering patient-centered care in the dialysis market, prioritizing comfort, quality of life, and personalized treatment plans tailored to individual needs. 𝑰𝒏𝒏𝒐𝒗𝒂𝒕𝒊𝒗𝒆 𝑻𝒉𝒆𝒓𝒂𝒑𝒊𝒆𝒔: Beyond conventional hemodialysis, there's a growing interest in alternative dialysis modalities such as peritoneal dialysis, home hemodialysis, and nocturnal dialysis, offering patients more flexibility and autonomy in managing their treatment. 𝑪𝒐𝒍𝒍𝒂𝒃𝒐𝒓𝒂𝒕𝒊𝒗𝒆 𝑬𝒇𝒇𝒐𝒓𝒕𝒔: Collaboration between healthcare institutions, technology companies, and research organizations is driving further advancements in dialysis care, fostering a collaborative ecosystem aimed at improving patient outcomes and reducing healthcare costs. 𝑴𝒂𝒋𝒐𝒓 𝑴𝒂𝒓𝒌𝒆𝒕 𝑷𝒍𝒂𝒚𝒆𝒓𝒔: Several market players operating in the dialysis industry include Baxter International Inc., DaVita Kidney Care, Nikkiso Co Ltd, NxStage Medical, Inc., Asahi Kasei, The Medicator's LLC, Fresenius Medical Care AG & Co. KGaA, Nipro Medical Corporation, B. Braun Avitum AG, Diaverum Deutschland GmbH, and others are provided in the dialysis market report. Let's continue to stay informed and engaged in the dialysis market, supporting initiatives that promote innovation, accessibility, and quality care for patients worldwide! Together, we can make a difference in renal health. #dialysismarket #healthcareinnovation #patientcare #globalhealthcare #medicaldevices #lifesciences #marketresearch #markettrends #businessinsights

𝑬𝒙𝒄𝒊𝒕𝒊𝒏𝒈 𝑼𝒑𝒅𝒂𝒕𝒆𝒔 𝒊𝒏 𝒕𝒉𝒆 𝑫𝒊𝒂𝒍𝒚𝒔𝒊𝒔 𝑴𝒂𝒓𝒌𝒆𝒕! 𝑹𝒆𝒒𝒖𝒆𝒔𝒕 𝒇𝒐𝒓 𝒂 𝑭𝑹𝑬𝑬 𝑺𝒂𝒎𝒑𝒍𝒆: https://lnkd.in/gV6YMN_T As the healthcare industry continues to innovate and evolve, I'm thrilled to share some key insights into the dialysis market! Here's a glimpse into the latest developments: 𝑴𝒂𝒓𝒌𝒆𝒕 𝑮𝒓𝒐𝒘𝒕𝒉: The dialysis market has been experiencing steady growth, driven by factors such as increasing prevalence of kidney diseases, technological advancements, and growing awareness about renal health. 𝑻𝒆𝒄𝒉𝒏𝒐𝒍𝒐𝒈𝒊𝒄𝒂𝒍 𝑨𝒅𝒗𝒂𝒏𝒄𝒆𝒎𝒆𝒏𝒕𝒔: Innovations in dialysis technology have been remarkable, with the introduction of wearable and portable dialysis devices, enhanced filtration techniques, and improved biocompatible materials, offering greater convenience and efficiency for patients. 𝑮𝒍𝒐𝒃𝒂𝒍 𝑹𝒆𝒂𝒄𝒉: The demand for dialysis services is not limited to any particular region, with significant growth observed worldwide. Emerging economies are witnessing a surge in demand for dialysis treatments due to changing lifestyles and rising incidences of chronic diseases. 𝑷𝒂𝒕𝒊𝒆𝒏𝒕-𝑪𝒆𝒏𝒕𝒆𝒓𝒆𝒅 𝑪𝒂𝒓𝒆: Healthcare providers are increasingly focusing on delivering patient-centered care in the dialysis market, prioritizing comfort, quality of life, and personalized treatment plans tailored to individual needs. 𝑰𝒏𝒏𝒐𝒗𝒂𝒕𝒊𝒗𝒆 𝑻𝒉𝒆𝒓𝒂𝒑𝒊𝒆𝒔: Beyond conventional hemodialysis, there's a growing interest in alternative dialysis modalities such as peritoneal dialysis, home hemodialysis, and nocturnal dialysis, offering patients more flexibility and autonomy in managing their treatment. 𝑪𝒐𝒍𝒍𝒂𝒃𝒐𝒓𝒂𝒕𝒊𝒗𝒆 𝑬𝒇𝒇𝒐𝒓𝒕𝒔: Collaboration between healthcare institutions, technology companies, and research organizations is driving further advancements in dialysis care, fostering a collaborative ecosystem aimed at improving patient outcomes and reducing healthcare costs. 𝑴𝒂𝒋𝒐𝒓 𝑴𝒂𝒓𝒌𝒆𝒕 𝑷𝒍𝒂𝒚𝒆𝒓𝒔: Several market players operating in the dialysis industry include Baxter International Inc., DaVita Kidney Care, Nikkiso Co Ltd, NxStage Medical, Inc., Asahi Kasei, The Medicator's LLC, Fresenius Medical Care AG & Co. KGaA, Nipro Medical Corporation, B. Braun Avitum AG, Diaverum Deutschland GmbH, and others are provided in the dialysis market report. Let's continue to stay informed and engaged in the dialysis market, supporting initiatives that promote innovation, accessibility, and quality care for patients worldwide! Together, we can make a difference in renal health. #dialysismarket #healthcareinnovation #patientcare #globalhealthcare #medicaldevices #lifesciences #marketresearch #markettrends #businessinsights

Order your 'Global Hemodialysis and Peritoneal Dialysis Market - Forecasts to 2029' FREE Sample Report via https://lnkd.in/d_jmDjgj Exciting news in healthcare! Let's talk about how advancements in technology and medical devices are shaping the future of the Hemodialysis and Peritoneal Dialysis Market by 2029. The field of dialysis is undergoing a remarkable transformation, driven by innovations in medical technology. As someone who's deeply invested in healthcare, I'm thrilled to see how these advancements will impact patient care and industry growth. Firstly, technology is enhancing the efficiency and effectiveness of hemodialysis and peritoneal dialysis treatments. Improved dialysis machines are becoming more intuitive and user-friendly, optimizing therapy delivery and patient outcomes. This not only improves the quality of life for patients but also reduces the burden on healthcare providers. Moreover, the integration of telemedicine and remote monitoring into dialysis care is revolutionizing how patients receive treatment. Remote monitoring devices allow real-time tracking of vital signs and treatment parameters, enabling proactive interventions and personalized care plans. This shift towards remote care is especially meaningful in improving access to dialysis services, particularly in underserved areas. Looking ahead to 2029, these advancements will likely drive significant growth in the hemodialysis and peritoneal dialysis market. Market expansion will be fueled by increasing prevalence of end-stage renal disease (ESRD), rising awareness about kidney health, and the growing adoption of home-based dialysis solutions. As a healthcare professional, I believe that collaboration between technology innovators, healthcare providers, and policymakers is crucial to capitalize on these opportunities. Together, we can ensure that patients receive the best possible care while managing costs and enhancing operational efficiencies within the healthcare system. I'm curious to hear your thoughts! How do you envision the future of dialysis care? Share your insights below. Baxter International Inc. B. Braun Group Fresenius Medical Care Medtronic Asahi Kasei Nipro Medical Corporation DaVita Kidney Care BD NIKKISO CRYO INC Cantel Medical #GlobalHemodialysisandPeritonealDialysisMarket #GlobalMarketEstimates #GME #HealthTech #DialysisCare #MedicalInnovation #HealthcareInnovation #MedTech #FutureOfHealthcare

Hemodialysis and Peritoneal Dialysis Market wort $126.2 billion by 2029 Download PDF Brochure @ https://lnkd.in/dYssGN5u The size of global 𝐡𝐞𝐦𝐨𝐝𝐢𝐚𝐥𝐲𝐬𝐢𝐬 𝐚𝐧𝐝 𝐩𝐞𝐫𝐢𝐭𝐨𝐧𝐞𝐚𝐥 𝐝𝐢𝐚𝐥𝐲𝐬𝐢𝐬 𝐦𝐚𝐫𝐤𝐞𝐭 𝐢𝐧 𝐭𝐞𝐫𝐦𝐬 𝐨𝐟 𝐫𝐞𝐯𝐞𝐧𝐮𝐞 𝐰𝐚𝐬 𝐞𝐬𝐭𝐢𝐦𝐚𝐭𝐞𝐝 𝐭𝐨 𝐛𝐞 𝐰𝐨𝐫𝐭𝐡 $92.0 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 2024 𝐚𝐧𝐝 𝐢𝐬 𝐩𝐨𝐢𝐬𝐞𝐝 𝐭𝐨 𝐫𝐞𝐚𝐜𝐡 $126.2 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 2029, 𝐠𝐫𝐨𝐰𝐢𝐧𝐠 𝐚𝐭 𝐚 𝐂𝐀𝐆𝐑 𝐨𝐟 6.5% from 2024 to 2029 Emerging markets such as #China, #India, #Brazil, are expected to offer significant growth opportunities for players operating in the #POCdiagnostics market. This is primarily due to the high and growing prevalence of #diabetes, #chronickidneydiseases, in these countries. As economic growth in China and India continues to expand, there is rise in healthcare spending across these countries, which leads to improved affordability of hemodialysis and peritoneal dialysis treatment. According to the article published by 𝐁𝐌𝐂 𝐍𝐞𝐩𝐡𝐫𝐨𝐥𝐨𝐠𝐲 in China, the prevalence of ESRD is projected to reach 1,505 patients per million population by 2025. To meet the increasing demand for #dialysis in the emerging markets, players focus on acquiring or entering into agreements and partnerships with healthcare providers. 𝐄𝐧𝐭𝐞𝐫𝐩𝐫𝐢𝐬𝐞𝐬 𝐨𝐩𝐞𝐫𝐚𝐭𝐢𝐧𝐠 𝐰𝐢𝐭𝐡𝐢𝐧 𝐭𝐡𝐢𝐬 𝐢𝐧𝐝𝐮𝐬𝐭𝐫𝐲: Q Medical Industries      Hanover & District Hospital      Physician Software Systems      SCW Medicath     Farmasol Tıbbi Ürünler San. ve Tic. A.Ş.      Renal Associates of Baton Rouge, LLC.       Northern California Nursing Academy      PT. Arianda Putra Pratama      Freedom At Home Dialysis      CEREHA S.A.      Inspira Health Group      PT. Oriontama Jaya      Vascular Surgery Associates      RenalWorks      tek-imaş Medıkal      Tianck Medical Co.,Ltd      PT Sing Aji Sentosa      SMT GROUP      Alzahra-Hospital      Austin Kidney Associates      Mobil Dialysis     Midwest Nephrology Associates      Meditechsys      Adventist Hospital Cebu      Sanxin Medtec      Hasheminejad Kidney Center      Physicians Choice Dialysis      Diaverum Hungary  North Mountain Medical and Rehabilitation Center     Nelson Environmental Technologies, Inc.      San Antonio Kidney      Haddon Renal Medical Specialsts      Dialyspa      Ayamed      Eastbrook Healthcare Center      The Medical City South Luzon         Biocompany Comércio e Serviços Ltda.   

𝐃𝐢𝐚𝐥𝐲𝐬𝐢𝐬 𝐅𝐢𝐥𝐭𝐞𝐫 𝐌𝐚𝐫𝐤𝐞𝐭 size was valued at $91,205.0 Million in 2020, and is estimated to reach $129,756.8 Million by 2028, registering a CAGR of 4.7% from 2021 to 2028 𝐂𝐥𝐢𝐜𝐤 𝐇𝐞𝐫𝐞, 𝐓𝐨 𝐆𝐞𝐭 𝐅𝐫𝐞𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 https://lnkd.in/g8BSWzXE 🔍 Key Insights: Renal Replacement Therapy: Dialysis filters, also known as dialyzers or artificial kidneys, are essential components of hemodialysis and hemofiltration systems used in the treatment of end-stage renal disease (ESRD) and acute kidney injury (AKI). These filters function as semipermeable membranes, removing waste products, excess fluids, and electrolytes from the blood, while maintaining appropriate levels of essential substances, such as electrolytes and bicarbonate. Critical Treatment Modality: Dialysis therapy plays a critical role in managing kidney failure and maintaining fluid and electrolyte balance in patients with compromised kidney function. It serves as a life-sustaining therapy for individuals awaiting kidney transplantation or those who are not candidates for transplantation, providing ongoing renal support and symptom relief to improve clinical outcomes and enhance quality of life. Customized Solutions: The Dialysis Filter Market offers a diverse range of dialyzer products with varying specifications, sizes, surface areas, membrane compositions, and ultrafiltration rates to accommodate the unique needs and treatment requirements of individual patients. Advanced dialysis filters may feature biocompatible membranes, low-flux or high-flux designs, enhanced clearance properties, and online monitoring capabilities to optimize treatment efficacy, minimize complications, and maximize patient safety. #Company B. Braun Group Nipro Medical Corporation Beldico Belgium Kawasumi Laboratories America Lepu Medical Technology (Beijing) Co., Ltd. Guangdong Baihe Medical Technology Co., Ltd. Guangdong Biolight Meditech Co., Ltd. Trivitron Healthcare Weigao #Type • High Throughput (Kuf>20mL/h/mmHg) • Low Throughput (Kuf<10mL/h/mmHg) #Application • Hospitals • Dialysis Centers • Others #Dialysis #RenalReplacementTherapy #KidneyHealth #Innovation

𝗔𝗰𝘂𝘁𝗲 𝗥𝗲𝘀𝗽𝗶𝗿𝗮𝘁𝗼𝗿𝘆 𝗗𝗶𝘀𝘁𝗿𝗲𝘀𝘀 𝗦𝘆𝗻𝗱𝗿𝗼𝗺𝗲 (𝗔𝗥𝗗𝗦) 𝗧𝗿𝗲𝗮𝘁𝗺𝗲𝗻𝘁 𝗠𝗮𝗿𝗸𝗲𝘁 𝟮𝟬𝟮𝟰-𝟮𝟬𝟯𝟭. 𝗚𝗹𝗼𝗯𝗮𝗹 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗥𝗲𝗽𝗼𝗿𝘁 The research report offers a comprehensive overview of the Acute Respiratory Distress Syndrome (ARDS) Treatment industry chain, assessing the market status within Hospital Pharmacy and Retail Pharmacy sectors, covering both oral and intravenous injection formats. It identifies key enterprises across developed and developing markets and examines cutting-edge technologies, patents, hot applications, and market trends within ARDS Treatment. Regionally, the report conducts an analysis of ARDS Treatment markets in key regions, noting steady growth in North America and Europe driven by government initiatives and increasing consumer awareness. Meanwhile, Asia-Pacific, especially China, leads the global ARDS Treatment market with strong domestic demand, supportive policies, and a robust manufacturing infrastructure. The market is segmented by type and application, with precise forecasts from 2024 to 2031 for consumption value by type and application, focusing on market valuation. 𝗧𝗼 𝗞𝗻𝗼𝘄 𝗚𝗹𝗼𝗯𝗮𝗹 𝗦𝗰𝗼𝗽𝗲 𝗮𝗻𝗱 𝗗𝗲𝗺𝗮𝗻𝗱 𝗼𝗳 𝗔𝗰𝘂𝘁𝗲 𝗥𝗲𝘀𝗽𝗶𝗿𝗮𝘁𝗼𝗿𝘆 𝗗𝗶𝘀𝘁𝗿𝗲𝘀𝘀 𝗦𝘆𝗻𝗱𝗿𝗼𝗺𝗲 (𝗔𝗥𝗗𝗦) 𝗧𝗿𝗲𝗮𝘁𝗺𝗲𝗻𝘁 𝗠𝗮𝗿𝗸𝗲𝘁. 𝗥𝗲𝗾𝘂𝗲𝘀𝘁 𝗳𝗼𝗿 𝗦𝗮𝗺𝗽𝗹𝗲 𝗣𝗗𝗙: https://lnkd.in/gwJhB94c *𝗕𝘆 𝗧𝘆𝗽𝗲: Oral, Intravenous Injection, Intramuscular Injection *𝗕𝘆 𝗔𝗽𝗽𝗹𝗶𝗰𝗮𝘁𝗶𝗼𝗻: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy *𝗕𝘆 𝗥𝗲𝗴𝗶𝗼𝗻: North America, Europe, Asia-Pacific, South America, Middle East & Africa *𝗕𝘆 𝗞𝗲𝘆 𝗣𝗹𝗮𝘆𝗲𝗿𝘀: Gilead Sciences, Terumo Medical Corporation, Getinge, LivaNova, Medtronic, • ALung Technologies, now a part of LivaNova, Armstrong Medical Ltd, Eurosets, F. Hoffmann-La Roche Ltd., Fisher & Paykel Healthcare, Hamilton Medical, nice Neotech Medical Systems Pvt. Ltd., Nipro Medical Corporation, Pfizer, ResMed, Smiths Medical, WEINMANN Emergency Medical Technology #ARDS #respiratory #treatment #healthcare #criticalcare #medicine #pulmonology #ICU #medicalresearch #lunghealth #ventilators #intensivecare #hospital #ARDSawareness #lunginjury #medicalcare #patientcare #pneumonia #lungdisease #medicalscience #ventilation #pulmonary #health #intensivecareunit #medicaltreatment #respiratorytherapy #healthandwellness #healthcareproviders #ARDSmanagement

𝐈𝐧𝐟𝐮𝐬𝐢𝐨𝐧 𝐏𝐮𝐦𝐩 𝐌𝐚𝐫𝐤𝐞𝐭 - 𝐆𝐥𝐨𝐛𝐚𝐥 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐄𝐱𝐩𝐞𝐜𝐭𝐢𝐧𝐠 𝐑𝐞𝐯𝐞𝐧𝐮𝐞 𝐑𝐢𝐬𝐞 𝐨𝐟 𝐰𝐨𝐫𝐭𝐡 $26.2𝐁 𝐛𝐲 2029 𝐟𝐫𝐨𝐦 $17.1𝐁 𝐢𝐧 2023 Download Brochure to Get More Details: https://lnkd.in/dbK3CwR8 The report "Infusion Pump Market by Product (Devices: Insulin, Volumetric, Syringe, Enteral, Ambulatory, Implantable Pumps; Accessories), Type, Therapy (Chemo/Oncology, Diabetes, Hematology, Pediatrics), Setting (Hospitals, Home care) - Global Forecast to 2029", size is 17.1 billion for 2023 and is projected to reach USD 26.2 billion by 2029, at a CAGR of 7.3% during the forecast period. The growing number of #surgeries performed, and rising prevalence of #chronicdiseases are some factors that provide key opportunities for key players in the market. However, product recalls by some major players, and stringent regulations on manufacture of #infusion #pumps are expected to challenge/restrain the growth of the market. Companies Operating in the Global Market: BD Baxter International Inc. B. Braun Group ICU Medical Fresenius Kabi Medtronic Terumo Medical Corporation Nipro Medical Corporation Avanos Medical Insulet Corporation Tandem Diabetes Care JMS Medical Co. Ltd. Roche Diagnostics USA Teleflex Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Ypsomed Holding AG Micrel Medical Devices Epic Medical SOOIL Development Co., Ltd. Shenzhen MedRena Biotech Co., Ltd CODAN Medizinische Geräte GmbH Eitan Medical #InfusionPumps #MedicalDevices #HealthcareMarket #MarketGrowth #InfusionTherapy #MedicalTechnology #HealthcareInnovation #MarketTrends #HealthcareEquipment #PatientCare #InfusionPumpMarket #MedicalEquipment #HealthcareIndustry #MarketForecast #HealthcareDevices #MedicalResearch #HealthTech #HealthcareTrends #InfusionPumpGrowth #GlobalHealthcare #MarketAnalysis #InfusionPumpTechnology #MedicalSupply #InfusionSystems #PatientSafety #InfusionPumpMarketGrowth #HealthcareSolutions #MedicalInnovation #MarketInsight #HealthcareSector #FutureOfHealthcare #MedicalMarket #HealthcareDevelopment #MedicalIndustry #HealthcareFuture #MedicalDeviceMarket #HealthIndustry #InfusionPumpForecast #MedicalMarketTrends #HealthcareForecast

The global market for Blood Processing Consumables was estimated to be worth US$ 18430 million in 2023 and is forecast to a readjusted size of US$ 29800 million by 2030 with a CAGR of 6.3% during the forecast period 20242030According to our research the global market for medical devices is estimated at US$ 603 billion in the year 2023 and will be growing at a CAGR of 5% during next six years. #BloodProcessing #Healthcare #MedicalDevices #BloodBanks #Hospitals #BloodSafety #GlobalMarket #BloodConsumables #PatientCare #MedicalInnovation

Something we do not typically think about with #dialysis. Stay tuned for the release of my blog #DialysisDemocracy The Hidden Peril of Overdependence on Commercial Dialysate Dialysis patients in the United States depend on a vital fluid—dialysate—to stay alive. But what most people don’t realize is that the production of this life-saving solution is concentrated in the hands of a few major companies. This overdependence on a limited number of suppliers creates a precarious situation that could lead to devastating consequences if the supply chain is disrupted. Imagine what would happen if a natural disaster or a geopolitical event interrupted the production or delivery of dialysate. Dialysis centers, which patients rely on multiple times a week, would be left scrambling, with lives literally hanging in the balance. We’ve seen how fragile global supply chains are, especially during the COVID-19 pandemic, when even basic medical supplies became scarce. A similar disruption in the dialysate supply could force clinics to ration treatments or resort to alternatives that may not be as safe or effective. There’s also the issue of quality control. Dialysate is a complex mixture, and any slight mistake in its formulation can have serious, even fatal, consequences. In 2012, a batch of contaminated dialysate caused several deaths due to hyperkalemia, a condition where potassium levels in the blood become dangerously high (Koh, 2012). When only a few companies are responsible for the entire country’s supply, the stakes are incredibly high. One error can lead to widespread harm. The economic impact is another overlooked aspect. Dialysis is already expensive, and the cost of dialysate is a big part of that. If the few companies that control its production decide to raise prices, it could put additional financial strain on patients and healthcare providers, making an already difficult situation even worse. We need to think about how to reduce this dangerous overreliance. One idea is to create smaller, decentralized production facilities that could not only ensure a more stable supply but also offer the possibility of customizing the dialysate to better meet individual patient needs. Advances in #biotechnology, like synthetic or bioengineered dialysate, could also provide new ways to mitigate the risks associated with the current system (Smith et al., 2020). #HemodialysisSafety #DialysisCare #MedicalSupplyChain #HealthcareResilience #DialysateQuality #PatientSafety #BiotechnologyInMedicine #BiotechMonopoly #OpentoWork #Reshare Tim Fitzpatrick Jeffrey Gold Justin Hobgood, BSN, RN Tom Mueller References: Koh, J. (2012). Fatal hyperkalemia associated with a recall of dialysate concentrate. Journal of the American Society of Nephrology, 23(7), 1087-1092. Smith, T., Allen, S., & Roberts, P. (2020). Bioengineered dialysate: A future innovation in dialysis care. Nephrology Dialysis Transplantation, 35(2), 345-352.

𝗘𝘂𝗿𝗼𝗽𝗲 𝗣𝗼𝗶𝗻𝘁-𝗼𝗳-𝗖𝗮𝗿𝗲 𝗗𝗶𝗮𝗴𝗻𝗼𝘀𝘁𝗶𝗰𝘀 𝗠𝗮𝗿𝗸𝗲𝘁 𝘁𝗼 𝗯𝗲 𝗪𝗼𝗿𝘁𝗵 $𝟭𝟮.𝟵𝟴 𝗕𝗶𝗹𝗹𝗶𝗼𝗻 𝗯𝘆 𝟮𝟬𝟯𝟬 𝗥𝗲𝗾𝘂𝗲𝘀𝘁 𝗳𝗼𝗿 𝗦𝗮𝗺𝗽𝗹𝗲: https://lnkd.in/dmViSjPx The Europe point-of-care diagnostics market is projected to grow at a CAGR of 4.1% from 2024, reaching $12.98 billion by 2030. Key drivers of this growth include the rising prevalence of infectious and chronic diseases, increased adoption of advanced technologies to improve diagnostics, and the development of CLIA-waived PoC tests. Additionally, the growing number of in-house hospital laboratories opting for PoC diagnostics, along with healthcare professionals' preference for PoC tests over traditional lab tests, and the advancement of healthcare infrastructure across Europe, present significant growth opportunities. However, limited reimbursement policies and cost concerns may slightly hinder market expansion. 𝗘𝘂𝗿𝗼𝗽𝗲 𝗣𝗼𝗶𝗻𝘁-𝗼𝗳-𝗖𝗮𝗿𝗲 𝗗𝗶𝗮𝗴𝗻𝗼𝘀𝘁𝗶𝗰𝘀 𝗠𝗮𝗿𝗸𝗲𝘁 𝗦𝗲𝗴𝗺𝗲𝗻𝘁𝗮𝘁𝗶𝗼𝗻: *𝗕𝘆 𝗢𝗳𝗳𝗲𝗿𝗶𝗻𝗴: Consumables, Instruments, Software and Services *𝗕𝘆 𝗣𝗹𝗮𝘁𝗳𝗼𝗿𝗺: Lateral Flow Assays, Molecular Diagnostics, Other Platforms *𝗕𝘆 𝗧𝗲𝗰𝗵𝗻𝗶𝗾𝘂𝗲: Blood Glucose Monitoring, Infectious Disease Testing, Tumors/Cancer Markers Testing, Pregnancy and Fertility Testing, Cardiac Marker/Cardiac Metabolism Testing, Cholesterol/Lipid Profile Testing, Coagulation Testing, Hematology, Drugs of Abuse Testing, Urinalysis, Other PoC Testing *𝗕𝘆 𝗦𝗮𝗺𝗽𝗹𝗲 𝗧𝘆𝗽𝗲𝗵: Blood Sample, Nasopharyngeal Swab, Urine Sample, Saliva Sample, Other Sample Types *𝗕𝘆 𝗘𝗻𝗱 𝗨𝘀𝗲𝗿: Hospitals, Home care/self-testing, Physician Offices & Ambulatory Care Settings, Diagnostics Laboratories, Other End Use *𝗞𝗲𝘆 𝗣𝗹𝗮𝘆𝗲𝗿𝘀: Abbott, Siemens Healthineers, Danaher Corporation, BD, Thermo Fisher Scientific, bioMérieux, QuidelOrtho, SEKISUI Diagnostics, Chembio Diagnostics, Inc., EKF Diagnostics, Trinity Biotech, Werfen, Nova Biomedical #PointOfCareDiagnostics #EuropeHealthcare #POCMarketGrowth #MedicalDiagnostics #InfectiousDiseases #ChronicDiseaseManagement #HealthcareInnovation #CLIAwaivedTests #POCTechnology #HospitalLaboratories #DiagnosticsAdvancements #HealthcareInfrastructure #PatientCare #POCReimbursement #HealthcareEfficiency #MedicalTechnology #DiagnosticsSolutions #EuropePOCMarket #HealthcareProfessionals #DiagnosticsMarketGrowth